-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
Lexaria Bioscience Corp. quarterly/annual General and Administrative Expense history and growth rate from 2010 to 2024.
- Lexaria Bioscience Corp. General and Administrative Expense for the quarter ending August 31, 2024 was $1.32M, a 105% increase year-over-year.
- Lexaria Bioscience Corp. General and Administrative Expense for the twelve months ending August 31, 2024 was $3.85M, a 25.8% increase year-over-year.
- Lexaria Bioscience Corp. annual General and Administrative Expense for 2024 was $3.85M, a 25.8% increase from 2023.
- Lexaria Bioscience Corp. annual General and Administrative Expense for 2023 was $3.06M, a 38.3% decline from 2022.
- Lexaria Bioscience Corp. annual General and Administrative Expense for 2022 was $4.96M, a 0.23% decline from 2021.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Annual (USD)
General and Administrative Expense, YoY Annual Growth (%)